InventisBio Co., Limited (SHA:688382)
China · Delayed Price · Currency is CNY 14.38
-1.09 (-7.05%)
Oct 22, 2026, 4:00 PM EDT
InventisBio Market Cap
InventisBio has a market cap or net worth of 8.33 billion as of October 22, 2026. It is the 8,839th most valuable company in the world and the 1,816th biggest in China. Its market cap has decreased by 48.50% in one year.
Market Cap
8.33B
Enterprise Value
7.03B
Revenue
71.44M
Global Rank
Country Rank
#1,816 China
PE Ratio
n/a
ChartMarket Cap Chart
Since July 25, 2022, InventisBio's market cap has decreased from 8.79B to 8.33B, a decrease of -5.20%. That is a compound annual growth rate of -1.25%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 22, 2026 | 8.33B | -47.10% |
| Dec 31, 2025 | 15.75B | 105.38% |
| Dec 31, 2024 | 7.67B | -11.89% |
| Dec 29, 2023 | 8.71B | 14.01% |
| Dec 30, 2022 | 7.64B | -13.15% |
| Jul 25, 2022 | 8.79B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Chengzhi | 9.87B |
| Mabwell (Shanghai) Bioscience | 9.85B |
| Staidson (Beijing) BioPharmaceuticals | 9.84B |
| Pacific Shuanglin Bio-pharmacy | 9.12B |
| Novoprotein Scientific | 9.06B |
| Jiangsu Sinopep-Allsino Biopharmaceutical | 8.87B |
| Shanghai OPM Biosciences | 8.75B |
| Chongqing Genrix Biopharmaceutical | 8.62B |